Loading…
Body Good Studio was cited for unlawfully selling unapproved and misbranded compounded drug products, specifically semaglutide, over the internet to U.S. consumers. The company's website contained false and misleading claims stating that its compounded semaglutide products were made of "the same active ingredients" as FDA-approved drugs Ozempic and Wegovy, which violated sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act. This marketing implied the compounded products were equivalent to approved medications when compounded drugs are not FDA-approved, rendering them misbranded under federal law.